Zircon Biotech Co., Ltd was founded in 2016, concentrating on developing, producing and selling the high quality in-vitro diagnostic products, and provides relevant services. It is one of the “Mass entrepreneurship and innovation enterprises in Changshu City, Jiangsu Province. The company has long been committed to R&D and innovation in the field of in-vitro diagnosis. The products include automatic thrombelastic analyzer (ATEG), high-speed automatic coagulation analyzer and relevant reagents, etc. Up to now, Zircon has branches in Changshu city, Taizhou city, as well as in Beijing.
The former of Zircon Biotech is the first brand national enterprise to carry out the R&D and promotion of in-vitro diagnostic products in China. It has been deeply involved in relevant fields for nearly 30 years. Moreover, it has a professional and stable high-quality research and development team, covering clinical medicine, laboratory medicine, mechanical design and other related disciplines. It is in the leading position in the industry in terms of standard setting, registration and testing, clinical trials and quality management of in-vitro diagnostic products. Based on a deep understanding of clinical diagnosis needs, the company has continued to carry out technical research and achievement transformation, adhere to innovation as the core competitiveness, and a number of R & D achievements have been patented in China and international market. Meanwhile, the company accurately positioned the market demand, applied these core patent technologies in the company's diagnostic products, created a series of benchmark products with independent intellectual property rights, and gradually established a higher industry standard.
To build a modern industrial system, continuously improve innovation capability and deepen international cooperation, Zircon Biotech will continue to make unremitting efforts to promote the development of new generation in vitro diagnostic technology.